MYOCARDIAL BLOOD-FLOW RESPONSE TO PACING TACHYCARDIA AND TO DIPYRIDAMOLE INFUSION IN PATIENTS WITH DILATED CARDIOMYOPATHY WITHOUT OVERT HEART-FAILURE - A QUANTITATIVE ASSESSMENT BY POSITRON EMISSION TOMOGRAPHY
MYOCARDIAL BLOOD-FLOW RESPONSE TO PACING TACHYCARDIA AND TO DIPYRIDAMOLE INFUSION IN PATIENTS WITH DILATED CARDIOMYOPATHY WITHOUT OVERT HEART-FAILURE - A QUANTITATIVE ASSESSMENT BY POSITRON EMISSION TOMOGRAPHY
复制标题
DOI:
10.1161/01.cir.92.4.796
复制
发表时间:
1995-08-15
期刊:
影响因子:
37.8
通讯作者:
LABBATE, A
中科院分区:
文献类型:
--
作者:
NEGLIA, D;PARODI, O;LABBATE, A
Background Myocardial blood flow (MBF) impairment has been documented in advanced dilated cardiomyopathy (DCM) in which hemodynamic factors, secondary to severe ventricular dysfunction, may limit myocardial perfusion. To assess whether MBF impairment in DCM may also be present independent of hemodynamic factors, the present study was designed to quan tify myocardial perfusion in patients with mild disease without overt heart failure.Methods and Results Absolute regional MBF (milliliters per minute per gram) was measured by positron emission tomography and N-13-ammonia in resting conditions, during pacing-induced tachycardia, and after dipyridamole infusion (0.56 mg/kg over 4 minutes) in 22 DCM patients and in 13 healthy subjects. Patients were in New York Heart Association functional class I-II and showed depressed left ventricular (LV) ejection fraction by radionuclide angiography (35+/-8%; range, 21% to 48%), normal coronary angiography, and normal or moderately increased LV end-diastolic pressure (9.2+/-5.5 mm Hg; range, 2 to 20 mm Hg). There were no differences in arterial blood pressure, heart rate, and rate-pressure product between patients and control subjects in the three study conditions. Compared with control subjects, DCM patients had lower mean MBF at rest (0.80+/-0.25 versus 1.08+/-0.20 mL . min(-1). g(-1), P